Summary
Pfizer Inc. (PFE) filed an 8-K report on June 26, 2014, to announce a change in its Board of Directors. The company's Board size was increased from 12 to 13 members, and James C. Smith was elected as a new director, effective immediately. Mr. Smith's appointment includes his service on two key Board committees: the Corporate Governance Committee and the Science and Technology Committee. He will be compensated according to Pfizer's standard policies for non-employee directors and has been provided with an indemnification agreement. This filing also includes the press release detailing Mr. Smith's election as an exhibit.
Key Highlights
- 1Pfizer Inc. expanded its Board of Directors from 12 to 13 members.
- 2James C. Smith was elected as a new member of the Board of Directors, effective immediately.
- 3Mr. Smith has been appointed to the Corporate Governance Committee.
- 4Mr. Smith has also been appointed to the Science and Technology Committee.
- 5The company will compensate Mr. Smith according to its standard arrangements for non-employee directors.
- 6Mr. Smith has been provided with an indemnification agreement.
- 7A press release dated June 26, 2014, announcing the election of Mr. Smith is attached as an exhibit.